Katherine H Powers, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 142 Terrace Ave, Riverside, RI 02915 Phone: 508-642-6600 |
News Archive
Groups that oppose abortion rights are calling on President Bush to withdraw the nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency because FDA might approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B for women ages 18 and older.
Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy's high price.
CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.
CHDI Foundation, Inc. and Lundbeck today announced a research collaboration to investigate a targeted therapy for Huntington's disease (HD). Currently, no treatment exists to slow or halt the progression of HD, a challenging hereditary neurodegenerative disease characterized by a triad of behavioral, cognitive, and motor symptoms.
› Verified 3 days ago